Clonal deletion of thymocytes as a tumor escape mechanism

International Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 216-222

  Lauritzsen, Grete F ^a,b   Hofgaard, Peter O ^a   Schenck, Karl ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; DENDRITIC CELLS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MULTIPLE MYELOMA; MYELOMA PROTEINS; PLASMACYTOMA; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 0031716744     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981005)78:2<216::AID-IJC16>3.0.CO;2-8     Document Type: Article

References (21)

1. BLICHFELDT, E., MUNTHE, L. A., ROTNES, J. S. and BOGEN, B., Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor. Europ. J. Immunol., 26, 2876-2884 (1996).
2. + T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Europ. J. Immunol., 26, 2671-2679 (1996).
3. BOGEN, B., DEMBIC, Z. and WEISS, S., Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J., 12, 357-363 (1993).
4. BOGEN, B., GLEDITSCH, L., WEISS, S. and DEMBIC, Z., Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. Europ. J. Immunol., 22, 703-709 (1992).
5. + T cells confer idiotype-specific tumor resistance in the absence of antibodies. Europ. J. Immunol., 25, 3079-3086 (1995).
6. CHEN, L., ASHE, S., BRADY, W. A., HELLSTROM, I., HELLSTROM, K. E., LEDBETTER, J. A., MCGOVAN, P. and LINSLEY, P. S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102 (1992).
7. GARRIDO, F., CABRERA, T., CONCHA, A., GLEW, S., RUIZ-CABELLO, F. and STERN, P. L., Natural history of HLA expression during tumour development. Immunol. Today, 14, 491-498 (1993).
8. HAHNE. M., RIMOLDI, D., SCHROTER, M., ROMERO, P., SCHREIER, M., FRENCH, L. E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIENARD, D., CEROTTINI, J.-C. and TSCHOPP, J., Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science, 274, 1363-1366 (1996).
9. KAKLAMANIS, L., LEEK, R., KOUKOURAKIS, M., GATTER, K.C. and HARRIS, A.L., Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55, 5191-5194 (1995).
10. KWAK, L.W., TAUB, D.D., DUFFEY, P.L., BENSINGER, W.I., BRYANT, E.M., REYNOLDS, C.W. and LONGO, D.L., Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016-1020 (1995).
11. + T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell. Immunol., 148, 177-188 (1993).
12. + T cells and immunosurveillance of B-cell tumors. Proc. nat. Acad. Sci. (Wash.), 91, 5700-5704 (1994).
13. LEVY, R. and MILLER, R.A., Therapy of lymphoma directed at idiotypes. Monogr. nat. Cancer Inst., 10, 61-68 (1990).
14. LYNCH, R. G., GRAFF, R. J., SIRISINHA, S., SIMMS, E. S. and EISEN, H. N., Myeloma proteins as tumor-specific transplantation antigens. Proc. nat. Acad. Sci. (Wash.), 69, 1540-1544 (1972).
15. NIEUWENHUIS, P., STET, R.J., WAGENAAR, J.P., WUBBENA, A.S., KAMPINGA, J. and KARRENBELD, A., The transcapsular route: a new way for (self-) antigens to by-pass the blood-thymus barrier? Immunol. Today, 9, 372-375 (1988).
16. NOSSAL, G. J., Tolerance and ways to break it. Ann. N.Y. Acad. Sci., 690, 34-41 (1993).
17. RAVIOLA, E. and KARNOVSKY, M.J., Evidence for a blood-thymus barrier using electron-opaque tracers. J. exp. Med., 136, 466-498 (1972).
18. STEVENSON, F.K., ZHU, D., KING, C. A., ASHWORTH, L. J., KUMAR, S. and HAWKINS, R. E., Idiotypic DNA vaccines against B-cell lymphoma. Immunol. Rev., 145, 211-228 (1995).
19. +thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature (Lond.), 351, 150-153 (1991).
20. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
21. VOLKMANN, A., ZAL, T. and STOCKINGER, B., Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol., 158, 693-706 (1997).